Non-Alcoholic Fatty Liver Disease (NAFLD): The Importance of Patient Engagement in Improving Clinical Trial Recruitment, New Webinar Hosted by Xtalks
![Xtalks Life Science Webinars](files/a6/9d/06a5e6b451d43cc6b8c2e84fb178.jpg)
TORONTO, May 16, 2018 (Newswire.com) - Non-alcoholic fatty liver disease (NAFLD) is a progressive disorder with increasing prevalence. There are currently no FDA-approved treatments for the disease, and lifestyle improvements play a large role in disease management.
A recent study conducted by Syneos Health shows that patients lack understanding of disease causes, implications and prognosis. This is a large gap in the current standard of care which not only causes confusion and anxiety that impacts their ability to take charge of their own health but is also likely a limiting factor in clinical trial participation. Clinical trials should be incorporated into the current standard of care as an option for NAFLD patients while more robust clinical guidelines are developed. Sponsors have a significant opportunity to address important unmet needs for patients, even as their own research progresses to find new treatments.
This live webinar upcoming on Thursday, May 24, 2018, at 10 a.m. EDT (3 p.m. BST/UK), will provide new real-world insight to better understand the trends and patterns associated with the typical journey of patients living with NAFLD.
- Gain insights into the NAFLD patient journey and perceptions
- Better understand specific factors impacting clinical trial participation
- Recognize informational, educational and support needs of patients to help drive better trial performance
Join industry experts from Syneos Health including Alastair Smith, senior director of medical management and scientific services, and Nicole Bass, director of medical management and scientific services, for an informative and interactive session.
For more information or complimentary registration, visit Non-Alcoholic Fatty Liver Disease (NAFLD): The Importance of Patient Engagement in Improving Clinical Trial Recruitment.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private and academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: [email protected]
Source: Xtalks
Share:
Tags: clinical trials, hepatology, Non-alcoholic fatty liver disease (NAFLD), patient recruitment, Syneos Health, Xtalks